Christian Schoergenhofer

Follow

Generating author description...

All published works

Action	Title	Year	Authors
+	Endpoints for randomized controlled clinical trials for COVID-19 treatments	2020	Lori E. Dodd Dean Follmann Jing Wang Franz Koenig Lisa L. Korn Christian Schoergenhofer Michael A. Proschan S. Hunsberger Tyler Bonnett Mat Makowski
+	Endpoints for randomized controlled clinical trials for COVID-19 treatments	2020	Lori E. Dodd Dean Follmann Jing Wang Franz Koenig Lisa L. Korn Christian Schoergenhofer Michael A. Proschan S. Hunsberger Tyler Bonnett Mat Makowski

Common Coauthors

Coauthor	Papers Together
Franz Koenig	2
Michael A. Proschan	2
Lori E. Dodd	2
Jing Wang	2
Yeming Wang	2
Tyler Bonnett	2
S. Hunsberger	2
Thomas Jaki	2
Drifa Belhadi	2
Dean Follmann	2
Mat Makowski	2
Lisa L. Korn	2
Bin Cao	1
France Mentré	1
Bin Cao	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Measurement in clinical trials: A neglected issue for statisticians?	2009	Stephen Senn Steven A. Julious	1
+	A Proportional Hazards Model for the Subdistribution of a Competing Risk	1999	Jason P. Fine Malcolm H. Ray	1
+	A mixed‐effects multinomial logistic regression model	2003	Donald Hedeker	1
+	Comparison of an ordinal endpoint to time-to-event, longitudinal, and binary endpoints for use in evaluating treatments for severe influenza requiring hospitalization	2019	Ross L Peterson David M. Vock Abdel Babiker John H. Powers Sally Hunsberger Brian Angus Armando Paez James D. Neaton	1
+	Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19	2020	Nigel Stallard Lisa V. Hampson Norbert Benda Werner Brannath Thomas Burnett Tim Friede Peter Kimani Franz Koenig Johannes Krisam Pavel Mozgunov	1